Biogen
BIIB
#661
Rank
ยฃ28.27 B
Marketcap
ยฃ191.30
Share price
0.25%
Change (1 day)
48.97%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) Fails to deliver data

Key failure to deliver metrics for Biogen:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Biogen (BIIB) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Biogen (BIIB) - since 2013

Volume in USD (price x number of shares), data since 2013

Biogen (BIIB) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ38.65 M-49%
2025ยฃ75.79 M5.44%
2024ยฃ71.88 M27.44%
2023ยฃ56.4 M-14.65%
2022ยฃ66.08 M7.92%
2021ยฃ61.24 M-56.04%
2020ยฃ0.13 B67.82%
2019ยฃ83.01 M-43.79%
2018ยฃ0.14 B69.32%
2017ยฃ87.22 M-29.4%
2016ยฃ0.12 B-16.47%
2015ยฃ0.14 B-18.15%
2014ยฃ0.18 B579.65%
2013ยฃ26.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ0.11 Bยฃ0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ34.29 Mยฃ0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ61.16 Mยฃ0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ29.91 Mยฃ0.45 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ21.42 Mยฃ38.26 M๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
ยฃ17.8 Mยฃ79.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ33.85 Mยฃ97.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/Aยฃ0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ81.11 Mยฃ0.13 B๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Bio-Rad Laboratories
BIO
ยฃ16.73 Mยฃ73.48 M๐Ÿ‡บ๐Ÿ‡ธ USA